Russia’s Zvyagintsev wins Jury Prize at 70th Cannes Film Festival with his LovelessSociety & Culture May 28, 21:32
Three Russian tourists hurt is road accident with tourist minibus in TurkeySociety & Culture May 28, 18:58
Some 40,000 cyclists taking part in Moscow cycle paradeSociety & Culture May 28, 18:33
Corporation Irkut: MS-21 first flight performed in routine modeBusiness & Economy May 28, 16:54
Ukrainian military launch more than 180 shells, mines on Donetsk within one dayWorld May 28, 16:36
Minister: Russia may supply 1,000 MC-21 planes to 2037Business & Economy May 28, 14:42
Lavrov: China, ASEAN interested in organization of Eurasian partnershipRussian Politics & Diplomacy May 28, 11:45
MC-21 airliner makes first test flight - sourceBusiness & Economy May 28, 11:00
Putin congratulates Border Guards on their professional holidayMilitary & Defense May 28, 10:57
MOSCOW, February 19. /TASS/. Russia’s Federal Antimonopoly Service (FAS) wants to introduce obligatory licensing of medicines to combat HIV in Russia to make them more affordable for the population, Lesya Davydova, head of the international economic department of the FAS said on Friday.
Currently, the prices for such medicines are quite high in Russia, which makes the medical treatment unaffordable for a large number of people. At the same time most of the anti-virus medicines are produced abroad and don’t have Russian analogues, she said.
Davydova said that in South Africa after the compulsory licensing of certain drugs (in particular those fighting HIV) the cost of treatment reduced tenfold.
"So here we also see a lot of work we could do,"- she said.
In October 2015, representatives of 19 non-profit organizations to combat HIV appealed to Prime Minister Dmitry Medvedev to introduce compulsory licensing of antiretroviral drugs for the treatment of this disease.
In early February, the founder of the Pharmasyntez pharmaceutical company Vikram Puniya addressed to Russian President Vladimir Putin with a proposal to apply the mechanism of forced licensing of hepatitis drugs. Puniya also referred to the experience of the BRICS countries in this field. Putin promised to analyze the legal side of the case, and if such practice exists in other countries, to consider the proposal.